GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (TSX:OGI) » Definitions » Capex-to-Operating-Income

OrganiGram Holdings (TSX:OGI) Capex-to-Operating-Income : 0.00 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is OrganiGram Holdings Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

OrganiGram Holdings's Capital Expenditure for the three months ended in Mar. 2024 was C$-0.86 Mil. Its Operating Income for the three months ended in Mar. 2024 was C$-14.98 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


OrganiGram Holdings Capex-to-Operating-Income Historical Data

The historical data trend for OrganiGram Holdings's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganiGram Holdings Capex-to-Operating-Income Chart

OrganiGram Holdings Annual Data
Trend Apr12 Apr13 Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.55 18.08 - -

OrganiGram Holdings Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.06 - - - -

Competitive Comparison of OrganiGram Holdings's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, OrganiGram Holdings's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrganiGram Holdings's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OrganiGram Holdings's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where OrganiGram Holdings's Capex-to-Operating-Income falls into.



OrganiGram Holdings Capex-to-Operating-Income Calculation

OrganiGram Holdings's Capex-to-Operating-Income for the fiscal year that ended in Aug. 2021 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-12.295) / -72.839
=N/A

OrganiGram Holdings's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.857) / -14.977
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrganiGram Holdings  (TSX:OGI) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


OrganiGram Holdings Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


OrganiGram Holdings (TSX:OGI) Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
Executives
Donald Geoffrey Machum Director